Zhang Wenhong

Zhang Wenhong


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2023 in Cost Effectiveness and Resource Allocation
Verified
Journal Article
Open access
PDF file
TLTianyi Liu
Tianyi Liu
YZYiyang Zhan
Yiyang Zhan
SCSilei Chen
Silei Chen
ZWZhang Wenhong
Zhang Wenhong
CQChen Qu
Chen Qu
Background: In recent years, numerous guidelines and expert consensus have recommended the inclusion of digital technologies and products in cardiac rehabilitation. Digital therapeutics (DTx) is an evidence-based medicine that uses digital means for data collection and monitoring of indicators to control and optimize the treatment, management, and prevention of disease. Objective: This study collected and reviewed real-world data and built a model using health economics assessment methods to analyze the potential cost-effectiveness of DTx applied to home-based cardiac rehabilitation for patients with chronic heart failure. From the perspective of medical and health decision-makers, the economic value of DTx is evaluated prospectively to provide the basis and reference for the application decision and promotion of DTx. Methods: Markov models were constructed to simulate the outcomes of DTx for home-based cardiac rehabilitation (DT group) compared to conventional home-based cardiac rehabilitation (CH group) in patients with chronic heart failure. The model input parameters were clinical indicators and cost data. Outcome indicators were quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs). The robustness of the evaluation methods and results was tested using sensitivity analyses. Clinical indicators, cost data, and health utility values were obtained from real-world data, including clinical study data, published literature, and public website information. Results: The Markov model simulated a time span of 10 years, with a cycle set at one month, for 120 cycles. The results showed that the per capita cost of the CH group was 38,442.11 CNY/year, with a QALY of 0.7196 per person per year. The per capita cost of the DT group was 42,300.26 CNY/year, with a QALY of 0.81687 per person per year. The ICER per person was 39,663.5 CNY/QALY each year, which was below the willingness-to-pay threshold of 85,698 CNY (China's GDP per capita in 2022). Conclusions: DTx for home-based cardiac rehabilitation is an extremely cost-effective rehabilitation option compared with conventional home-based cardiac rehabilitation. DTx for home-based cardiac rehabilitation is potentially valuable from the perspective of healthcare decision-makers.

1 January 2023 in Digital Health
Verified
Journal Article
Open access
TLTianyi Liu
Tianyi Liu
ZTZhijie Tang
Zhijie Tang
CCCheng Cai
Cheng Cai
NWNan Wu
Nan Wu
JJJian Jia
Jian Jia
ZWZhang Wenhong
Zhang Wenhong
Background: In recent years, numerous guidelines and expert consensuses have recommended that digital technologies and products, such as digital therapeutics (DTx), be incorporated into cardiac rehabilitation (CR). Objective: The study aims to compare the cost-effectiveness of DTx for home-based CR (HBCR) with that of the conventional HBCR for patients with atrial fibrillation (AF) after catheter ablation in a real-world clinical setting. Methods: Based on a single-center, prospective, blinded, randomized, parallel controlled trial of DTx-based HBCR for AF patients after catheter ablation, 100 AF patients undergoing catheter ablation were selected and randomized at a 1:1 ratio into a UC group (conventional HBCR) and DT group (DTx-based HBCR). The intervention lasted for 12 weeks. Medical cost data and clinical efficacy data (VO2max) were acquired from trial data. Effect data (QALYs, anxiety and depression status, health beliefs related to cardiovascular disease, and exercise self-efficacy) were obtained from a patient questionnaire. The cost-effectiveness analysis was conducted to assess the economic benefits of DTx-based HBCR versus conventional HBCR, and the robustness of the results was verified by sensitivity analysis. Results: In the DT group (n = 49), the mean QALYs increased 0.119 ± 0.09, VO2max increased 9.3 ± 8.0 mL/(min*kg), anxiety, depression, health belief, and exercise self-efficacy had improved, and the total medical cost was 75,080.55 ± 19,746.62 CNY. In the UC group (n = 48), the mean QALYs increased 0.077 ± 0.06, VO2max increased 4.9 ± 6.6 mL/(min*kg), anxiety, depression, health belief, and exercise self-efficacy had improved, and the total medical cost was 73,972.66 ± 16,582.04 CNY. The difference in the medical cost was 1107.89 CNY, and the incremental cost-effectiveness ratio was 33,572.42 CNY/QALY, which was lower than the willingness-to-pay threshold of 85,698 CNY (China's per capita GDP in 2022). Conclusion: DTx-based HBCR is more effective and cost-effective than conventional HBCR.

1 February 2021 in Journal of Business & Industrial Marketing
Verified
Journal Article
Closed access
YZYapu Zhao
Yapu Zhao
DLDong Liu
Dong Liu
ZWZhang Wenhong
Zhang Wenhong
SCSilei Chen
Silei Chen
This paper aims to investigate how top management service commitment (TSC) affects two dimensions of new product development (NPD), speed and product innovativeness, and to examine how dysfunctional competition moderates the effects in emerging economies. Data were collected from 151 high-tech manufacturing firms in China. In one firm, two different top managers were surveyed to reduce the common method variance. The authors used the seemingly unrelated regression approach to test the hypotheses. First, TSC negatively influences product innovativeness, an effect that dysfunctional competition attenuates. Second, despite not being significantly positive as hypothesized, the direct effect of TSC on NPD speed remains positive when dysfunctional competition is high rather than low. Third, the findings reveal that product innovativeness increases firm performance, but NPD speed shows no similar effect. First, top managers should pay attention to the synergistic effect between industrial services and product businesses. Second, manufacturing firms in developing countries need to implement servitization when facing unlawful competitive behaviors. In literature, the effect of industrial services on NPD is unclear. The present study enriches literature by connecting servitization with NPD and by focusing on the importance of top managers to the implementation of servitization. In addition, the authors extend the servitization literature to emerging economies and thereby provide significant insights into this context.

16 July 2026 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
ZSZhonghua Sun
Zhonghua Sun
KWKexue Wang
Kexue Wang
CGChiwei Guo
Chiwei Guo
JQJiajun Qiu
Jiajun Qiu
WWWencai Wang
Wencai Wang
ZWZhang Wenhong
Zhang Wenhong
Early-stage cardiovascular-kidney-metabolic (CKM) syndrome, encompassing stages 0–3, represents a critical window for identifying individuals at risk

25 March 2026 in Tropical Medicine and Health
Verified
Journal Article
Open access
PDF file
ZSZhonghua Sun
Zhonghua Sun
YXYameng Xu
Yameng Xu
JXJiansheng Xiao
Jiansheng Xiao
XLXiaozhu Liu
Xiaozhu Liu
YSYuwen Shangguan
Yuwen Shangguan
ZWZhang Wenhong
Zhang Wenhong
Acute hepatitis B (AHB) and acute hepatitis C (AHC) remain major global health challenges despite the World Health Assembly’s 2030 elimination goals.

24 September 2024 in Chinese Management Studies
Verified
Journal Article
Closed access
XLXiuping Lai
Xiuping Lai
ZWZhang Wenhong
Zhang Wenhong
SCSilei Chen
Silei Chen
Purpose: Medical disruptive innovation is essential for deepening the reform of health-care system. The theory of general disruptive innovation assumes that innovations can diffuse by benefiting and attracting consumers through observed and objective relative advantages. Yet decision-makers for adoption in health-care settings are safety-sensitive professionals whose cognitions barriers about underperformance in focal attributes will impede further evaluation of innovation's ancillary performance. Existing studies do not answer the question of how such innovations can overcome safety barriers, find early adopters and grow to the early majority. The purpose of this study is to investigate the process, mechanism, and path of early diffusion of medical disruptive innovation. Design/methodology/approach: The authors conduct a longitudinal case study of the diffusion of Enhanced Recovery After Surgery (ERAS) in China during 2011–2018. Findings: The authors find that the diffusion process of medical disruptive innovations can be viewed as a cognitive evolutionary process that sequentially establishes conformity, differentiation and normalization. Cognition reframing of expert, meaning and benefit for professionals is its implicit mechanism. When adoption may trigger cognitive concerns, actors’ very early (dis)adoption is driven by a combination of structural position, innovation attributes and performance perceptions; central actors then play amplifier roles in the development from early adopters to the early majority. Originality/value: This study proposes a process theoretical framework for the early diffusion of disruptive innovation. By dissecting the key processes and mechanisms from a cognitive perspective, the study offers theoretical contributions and practical insights into the diffusion of disruptive innovation in professional settings.